Central Kentucky Research Associates Inc - Phase 2

Lexington, Kentucky 40509

0 studies enrolling now · 1 studies all time

What they study most

COVID-19

Studies at this site

• Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant — Completed